Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fu-Shun Yen
Chii-Min Hwu
Chih-Cheng Hsu

Showing results (1-10 of 485) with videos related to

Pageof 49
Sort By:
Diabetes Research and Clinical Practice|November 11, 2021
Early-onset type 2 diabetes <60 years and risk of vascular complicationsFu-Shun Yen, Yu-Ru Lo, Chii-Min Hwu, et al.
Frontiers in Medicine|January 23, 2023
Severe hypoglycemia in patients with liver cirrhosis and type 2 diabetesFu-Shun Yen, Ming-Chih Hou, Jia-Sin Liu, et al.
Plos One|October 5, 2018
Effects of metformin use on total mortality in patients with type 2 diabetes and chronic obstructive pulmonary disease: A matched-subject designFu-Shun Yen, Weishan Chen, James Cheng-Chung Wei, et al.
Journal of Diabetes Investigation|February 6, 2022
Similarities and differences in the natural history of youth-onset type 2 diabetes between the West and AsiaFu-Shun Yen, Chii-Min Hwu
BMC Endocrine Disorders|February 19, 2021
Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetesFu-Shun Yen, James Cheng-Chung Wei, Mei-Chen Lin, et al.
Journal of Medical Virology|November 4, 2022
Metformin use and the risks of herpes zoster and postherpetic neuralgia in patients with type 2 diabetesFu-Shun Yen, James Cheng-Chung Wei, Hei-Tung Yip, et al.
Plos One|June 24, 2020
Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with goutFu-Shun Yen, Chih-Cheng Hsu, Hsin-Lun Li, et al.
Diabetes Research and Clinical Practice|November 7, 2022
Long-term outcomes of the pay-for-performance program for patients with young-onset (20-40 years of age) type 2 diabetesFu-Shun Yen, James Cheng-Chung Wei, Yu-Tung Hung, et al.
JAMA Network Open|June 12, 2024
Sodium-Glucose Cotransporter-2 Inhibitors and Nephritis Among Patients With Systemic Lupus ErythematosusFu-Shun Yen, Shiow-Ing Wang, Chih-Cheng Hsu, et al.
Frontiers in Medicine|March 7, 2022
Selection and Warning of Evidence-Based Antidiabetic Medications for Patients With Chronic Liver DiseaseFu-Shun Yen, Chih-Cheng Hsu, James Cheng-Chung Wei, et al.
Pageof 49

Showing results (1-10 of 485) with videos related to

Sort By:
Pageof 49
Diabetes Research and Clinical Practice|November 11, 2021
Early-onset type 2 diabetes <60 years and risk of vascular complicationsFu-Shun Yen, Yu-Ru Lo, Chii-Min Hwu, et al.
Frontiers in Medicine|January 23, 2023
Severe hypoglycemia in patients with liver cirrhosis and type 2 diabetesFu-Shun Yen, Ming-Chih Hou, Jia-Sin Liu, et al.
Plos One|October 5, 2018
Effects of metformin use on total mortality in patients with type 2 diabetes and chronic obstructive pulmonary disease: A matched-subject designFu-Shun Yen, Weishan Chen, James Cheng-Chung Wei, et al.
Journal of Diabetes Investigation|February 6, 2022
Similarities and differences in the natural history of youth-onset type 2 diabetes between the West and AsiaFu-Shun Yen, Chii-Min Hwu
BMC Endocrine Disorders|February 19, 2021
Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetesFu-Shun Yen, James Cheng-Chung Wei, Mei-Chen Lin, et al.
Journal of Medical Virology|November 4, 2022
Metformin use and the risks of herpes zoster and postherpetic neuralgia in patients with type 2 diabetesFu-Shun Yen, James Cheng-Chung Wei, Hei-Tung Yip, et al.
Plos One|June 24, 2020
Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with goutFu-Shun Yen, Chih-Cheng Hsu, Hsin-Lun Li, et al.
Diabetes Research and Clinical Practice|November 7, 2022
Long-term outcomes of the pay-for-performance program for patients with young-onset (20-40 years of age) type 2 diabetesFu-Shun Yen, James Cheng-Chung Wei, Yu-Tung Hung, et al.
JAMA Network Open|June 12, 2024
Sodium-Glucose Cotransporter-2 Inhibitors and Nephritis Among Patients With Systemic Lupus ErythematosusFu-Shun Yen, Shiow-Ing Wang, Chih-Cheng Hsu, et al.
Frontiers in Medicine|March 7, 2022
Selection and Warning of Evidence-Based Antidiabetic Medications for Patients With Chronic Liver DiseaseFu-Shun Yen, Chih-Cheng Hsu, James Cheng-Chung Wei, et al.
Pageof 49